DK582588D0 - Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse - Google Patents
Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelseInfo
- Publication number
- DK582588D0 DK582588D0 DK582588A DK582588A DK582588D0 DK 582588 D0 DK582588 D0 DK 582588D0 DK 582588 A DK582588 A DK 582588A DK 582588 A DK582588 A DK 582588A DK 582588 D0 DK582588 D0 DK 582588D0
- Authority
- DK
- Denmark
- Prior art keywords
- c2h4o
- compound
- present
- treating
- hltv
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 229930182566 Gentamicin Natural products 0.000 abstract 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 239000007859 condensation product Substances 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 229960000285 ethambutol Drugs 0.000 abstract 1
- 229960002518 gentamicin Drugs 0.000 abstract 1
- 229960003350 isoniazid Drugs 0.000 abstract 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 abstract 1
- 125000000963 oxybis(methylene) group Chemical group [H]C([H])(*)OC([H])([H])* 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1733087A | 1987-02-20 | 1987-02-20 | |
| US15073188A | 1988-02-16 | 1988-02-16 | |
| PCT/US1988/000510 WO1988006038A1 (en) | 1987-02-20 | 1988-02-19 | Antiinfective compounds and method of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK582588D0 true DK582588D0 (da) | 1988-10-19 |
| DK582588A DK582588A (da) | 1988-12-12 |
Family
ID=26689732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK582588A DK582588A (da) | 1987-02-20 | 1988-10-19 | Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0305470B1 (da) |
| JP (1) | JPH01503458A (da) |
| AT (1) | ATE82129T1 (da) |
| AU (1) | AU1396588A (da) |
| CA (1) | CA1314221C (da) |
| DE (1) | DE3875871T2 (da) |
| DK (1) | DK582588A (da) |
| FI (1) | FI884850A0 (da) |
| WO (1) | WO1988006038A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5674911A (en) * | 1987-02-20 | 1997-10-07 | Cytrx Corporation | Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use |
| CN1069741A (zh) | 1991-03-19 | 1993-03-10 | 西特克斯公司 | 具有改进的生物活性的聚氧丙烯/聚氧乙烯共聚物 |
| USRE38558E1 (en) | 1991-03-19 | 2004-07-20 | Cytrx Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
| US6093391A (en) * | 1992-10-08 | 2000-07-25 | Supratek Pharma, Inc. | Peptide copolymer compositions |
| US6153193A (en) * | 1993-04-28 | 2000-11-28 | Supratek Pharma Inc. | Compositions for targeting biological agents |
| US5488034A (en) * | 1993-02-02 | 1996-01-30 | Xoma Corporation | Pharmaceutical composition comprising BPI proteins |
| US6214789B1 (en) | 1993-03-12 | 2001-04-10 | Xoma Corporation | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
| GB2281697A (en) * | 1993-09-14 | 1995-03-15 | Euro Celtique Sa | Laxative compositions in capsules |
| US5932544A (en) * | 1994-05-31 | 1999-08-03 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) compositions |
| US6353055B1 (en) | 1994-11-18 | 2002-03-05 | Supratek Pharma Inc. | Polynucleotide compositions |
| US6221959B1 (en) | 1994-11-18 | 2001-04-24 | Supratek Pharma, Inc. | Polynucleotide compositions |
| RU2146130C1 (ru) * | 1999-07-08 | 2000-03-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Фармацевтический состав, обладающий противотуберкулезной активностью |
| DE10358534A1 (de) | 2003-12-13 | 2005-07-14 | Henkel Kgaa | Adhäsionshemmung von Mikroorganismen durch nichtionische Tenside |
| RU2496475C2 (ru) | 2011-10-26 | 2013-10-27 | Александр Васильевич Иващенко | Фармацевтическая композиция и набор для лечения бактериальных инфекций |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2674619A (en) * | 1953-10-19 | 1954-04-06 | Wyandotte Chemicals Corp | Polyoxyalkylene compounds |
| US3140232A (en) * | 1962-12-19 | 1964-07-07 | Pfizer & Co C | Color stabilization of tetracycline compositions with polypropylene glycols |
| CA959759A (en) * | 1970-01-15 | 1974-12-24 | John J. Miskel | Method for absorption of drugs |
| JPS5283936A (en) * | 1976-01-01 | 1977-07-13 | Ortho Pharma Corp | Single herpes virus inactivating acent |
| DE2732929A1 (de) * | 1977-07-21 | 1979-02-01 | Bayer Ag | Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer |
| JPS5449322A (en) * | 1977-09-26 | 1979-04-18 | Daicel Chem Ind Ltd | Non-medical anti-bacterial and anti-mold agent |
| JPS5668616A (en) * | 1979-11-08 | 1981-06-09 | Yukio Kimura | Preparation of antibiotic composition |
| JPS579717A (en) * | 1980-06-20 | 1982-01-19 | Nippon Shinyaku Co Ltd | Germicidal composition |
| US4376118A (en) * | 1980-10-06 | 1983-03-08 | Miles Laboratories, Inc. | Stable nonaqueous solution of tetracycline salt |
| DE3234084A1 (de) * | 1982-09-14 | 1984-03-15 | B. Braun Melsungen Ag, 3508 Melsungen | Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung |
-
1988
- 1988-02-19 AU AU13965/88A patent/AU1396588A/en not_active Abandoned
- 1988-02-19 DE DE8888902681T patent/DE3875871T2/de not_active Expired - Fee Related
- 1988-02-19 EP EP88902681A patent/EP0305470B1/en not_active Expired - Lifetime
- 1988-02-19 JP JP63502373A patent/JPH01503458A/ja active Pending
- 1988-02-19 WO PCT/US1988/000510 patent/WO1988006038A1/en active IP Right Grant
- 1988-02-19 AT AT88902681T patent/ATE82129T1/de not_active IP Right Cessation
- 1988-02-22 CA CA000559454A patent/CA1314221C/en not_active Expired - Fee Related
- 1988-10-19 DK DK582588A patent/DK582588A/da not_active Application Discontinuation
- 1988-10-20 FI FI884850A patent/FI884850A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1396588A (en) | 1988-09-14 |
| ATE82129T1 (de) | 1992-11-15 |
| EP0305470B1 (en) | 1992-11-11 |
| JPH01503458A (ja) | 1989-11-22 |
| EP0305470A1 (en) | 1989-03-08 |
| WO1988006038A1 (en) | 1988-08-25 |
| DE3875871D1 (de) | 1992-12-17 |
| DK582588A (da) | 1988-12-12 |
| FI884850A7 (fi) | 1988-10-20 |
| DE3875871T2 (de) | 1993-04-01 |
| CA1314221C (en) | 1993-03-09 |
| FI884850A0 (fi) | 1988-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK582588D0 (da) | Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse | |
| Giamarellou et al. | In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa | |
| CA2006953A1 (en) | Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids. | |
| MX192812B (es) | Benzoxazinonas como inhibidores de hiv transcriptasa inversa. | |
| ZA901499B (en) | Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection | |
| US4096245A (en) | Prophylactic preparation for treating mink infection caused by Pseudomonas aeruginosa | |
| FI962488A0 (fi) | HIV:n proteaasin inhibiittoreita | |
| Steele | Recurrent staphylococcal infection in families | |
| Lawrence et al. | Quantitative microbiology of traumatic orthopedic wounds | |
| Gray et al. | The effect of topical povidone iodine on wound infection following abdominal surgery | |
| Chirino-Trejo et al. | Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis | |
| US3792161A (en) | Burn ointment comprising silver sulfadiazine and collagenase | |
| Holton et al. | Mycobacterium haemophilum infection in a patient with AIDS | |
| Vanhoof et al. | The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms | |
| Berger et al. | Penetration of clindamycin into decubitus ulcers | |
| Mallory et al. | Local immunization of rabbits to cutaneous infection with Staphylococcus aureus | |
| Callapina et al. | Systemic and intracerebral infections of mice with Listeria monocytogenes successfully treated with linezolid | |
| ES442505A1 (es) | Procedimiento de preparacion de la 4-0-n2',6'-diamino-2',3',6' - tridesoxi-alfa, d-ribohexopiranosiln6-0 - n3" - metila-mino-3",4",6"tridesoxi alfa,d-xilohexopiranosiln2-desoxies- treptamina. | |
| Duran et al. | In-vitro antimicrobial susceptibility of Bacteroides and Fusobacterium isolated from footrot in goats | |
| Bisgaard et al. | Isolation of Pasteurella caballi from an infected wound on a veterinary surgeon | |
| Lundberg et al. | Concentration of penicillin and tetracycline in maxillary sinus secretion after a single dose | |
| Dyas et al. | Sources of staphylococcal wound sepsis in surgical patients | |
| Ainslie et al. | Subconjunctival administration of soframycin in the treatment of corneal infections | |
| Belsheim et al. | Doxycycline prophylaxis in fracture surgery | |
| Soliman et al. | STUDIES ON HISTOPLASMOSIS FARCIMINOSSII (EPIZOOTIC LYMPHANGITIS) IN EGYPT IV-The biochemical characters of local isolates of Histoplasma Farcimonosum and their sensitiity to antimycotic and disinfectants in vitro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |